Cargando…

Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials

BACKGROUND: Tiotropium is generally well tolerated; however, there has been debate whether antimuscarinics, particularly tiotropium administered via Respimat® Soft Mist™ Inhaler, may induce cardiac arrhythmias in a vulnerable subpopulation with cardiovascular comorbidity. The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hohlfeld, J M, Furtwaengler, A, Könen-Bergmann, M, Wallenstein, G, Walter, B, Bateman, E D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Cardiovascular
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383643/ https://www.ncbi.nlm.nih.gov/pubmed/25496316 http://dx.doi.org/10.1111/ijcp.12596

Ejemplares similares

No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Tiotropium might improve survival in subjects with COPD at high risk of mortality
por: Burgel, Pierre-Régis, et al.
Publicado: (2014)

Second look Holter ECG in neurorehabilitation
por: Knecht, Stefan, et al.
Publicado: (2019)

Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials
por: Calverley, Peter M. A., et al.
Publicado: (2016)

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Heritability of ECG Biomarkers in the Netherlands Twin Registry Measured from Holter ECGs
por: Hodkinson, Emily C., et al.
Publicado: (2016)

Safety, tolerability and risk benefit analysis of tiotropium in COPD
por: Oba, Yuji, et al.
Publicado: (2008)

Efficacy and safety of tiotropium Respimat(®) SMI in COPD in two 1-year randomized studies
por: Bateman, Eric, et al.
Publicado: (2010)

Role of tiotropium in the treatment of COPD
por: Rice, Kathryn L, et al.
Publicado: (2007)

ECG monitoring of post-stroke occurring arrhythmias: an observational study using 7-day Holter ECG
por: Carrarini, Claudia, et al.
Publicado: (2022)

Tiotropium HandiHaler(®) in the treatment of COPD: A safety review
por: Kesten, Steven, et al.
Publicado: (2009)

Usefulness of measurement of heart rate variability by holter ECG in hemodialysis patients
por: Kida, Nanami, et al.
Publicado: (2017)

QRS detection and classification in Holter ECG data in one inference step
por: Ivora, Adam, et al.
Publicado: (2022)

Assessment of the atrial fibrillation burden in Holter ECG recordings using artificial intelligence
por: Hennings, E, et al.
Publicado: (2023)

Intermittent short ECG recording is more effective than 24-hour Holter ECG in detection of arrhythmias
por: Hendrikx, Tijn, et al.
Publicado: (2014)

Software‐based analysis of 1‐hour Holter ECG to select for prolonged ECG monitoring after stroke
por: Gröschel, Sonja, et al.
Publicado: (2020)

Whether and what abnormalities we find in ECG records and 24-hour Holter ECG in patients after COVID-19 without hospitalization with cardiac damage
por: Chudzik, M, et al.
Publicado: (2023)

Cardiac Ambulatory Monitoring: New Wireless Device Validated Against Conventional Holter Monitoring in a Case Series
por: Murali, Srinivasan, et al.
Publicado: (2020)

Tiotropium/Olodaterol: A Review in COPD
por: Blair, Hannah A.
Publicado: (2019)

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis
por: Halpin, David MG, et al.
Publicado: (2015)

Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation — the AGNES-ECG study
por: Sikorska, Agnieszka, et al.
Publicado: (2022)

Independent Component Analysis and Decision Trees for ECG Holter Recording De-Noising
por: Kuzilek, Jakub, et al.
Publicado: (2014)

Holter ECG for Syncope Evaluation in the Internal Medicine Department—Choosing the Right Patients
por: Freund, Ophir, et al.
Publicado: (2022)

Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies
por: Ferguson, Gary T., et al.
Publicado: (2017)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
por: Ichinose, Masakazu, et al.
Publicado: (2018)

Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat(®) Soft Mist™ Inhaler in COPD
por: Hodder, Rick, et al.
Publicado: (2011)

Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial
por: Troosters, Thierry, et al.
Publicado: (2014)

The Diagnostic Value of Combined 24-h BP and ECG Holter Monitoring in Detection of Cardiac Arrhythmias in Patients with Arterial Hypertension
por: Naser, Nabil, et al.
Publicado: (2022)

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk
por: Covelli, Henry, et al.
Publicado: (2015)

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis
por: Miravitlles, Marc, et al.
Publicado: (2017)

Correction to: Tiotropium/Olodaterol: A Review in COPD
por: Blair, Hannah A.
Publicado: (2019)

QT dispersion on ECG Holter monitoring and risk of ventricular arrhythmias in patients with dilated cardiomyopathy
por: DE MARIA, ELIA, et al.
Publicado: (2006)

Obstructive Sleep Apnea as a Predictor of Arrhythmias in 24-h ECG Holter Monitoring
por: Urbanik, Dominika, et al.
Publicado: (2021)

Severe OSA Leading to Long Pauses in 24-h Holter ECG Reversed with CPAP
por: Mukhopadhyay, Mainak, et al.
Publicado: (2020)

Comparing the consistency of electrocardiogram interval measurements by resting ECG versus 12‐lead Holter
por: Mendzelevski, Boaz, et al.
Publicado: (2021)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
Publicado: (2018)

Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
por: Lan, Ying, et al.
Publicado: (2023)

The effect of tiotropium therapy on markers of elastin degradation in COPD
por: Ma, Shuren, et al.
Publicado: (2009)

Small airways ventilation heterogeneity and hyperinflation in COPD: Response to tiotropium bromide
por: Verbanck, Sylvia, et al.
Publicado: (2007)

Safety of tiotropium in patients with asthma
por: Dusser, Daniel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lje89gnd21s9vs98q61m684d06